Adequacy of access to investigative drugs for seriously ill patients :
hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, September 23, 1997.

Description

Corporate Author

United States. Congress.

Language(s)

English

Published

Washington : U.S. G.P.O. : 1997.

Subjects

Pharmacology, Experimental.
Medical ethics.
Human experimentation in medicine.
Drugs > Drugs / Testing.
Drug accessibility > Drug accessibility / Law and legislation.
Clinical trials.
Drug accessibility > Drug accessibility / Law and legislation > Drug accessibility / Law and legislation / United States.
Medical ethics > Medical ethics / United States.
Human experimentation in medicine > Human experimentation in medicine / United States.
Clinical trials > Clinical trials / United States.
Drugs > Drugs / United States > Drugs / United States / Testing.
Pharmacology, Experimental > Pharmacology, Experimental / United States.
United States.

Note

"Serial no. 105-44."
Shipping list no.: 98-0082-P.
Distributed to some depository libraries in microfiche.
Also available in digital form on the Library of Congress Web site.

Physical Description

iii, 78 pages ; 24 cm

ISBN

9780160557590
0160557593

Locate a Print Version

Find in a library

Viewability